Haematology 2018

NHL: A Heterogeneous Disease

PMLBCL (2%)

ALCL

MCL (6%)

- 75% of aggressive NHL - 40%: localized disease - 40-50%: extranodal disease

Burkitt’s

DLBCL (31%)

Other

CLL/SLL (6%)

FL (22%)

MALT/Nodal MZL (10%)